Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
The current Merck(MRK) stock price is $115.77, with a market capitalization of 285.87B. The stock trades at a price-to-earnings (P/E) ratio of 15.88 and offers a dividend yield of 2.8%.
On 2026-03-15, Merck(MRK) stock moved within a range of $115.25 to $117.89. With shares now at $115.77, the stock is trading +0.5% above its intraday low and -1.8% below the session's peak.
Trading volume for Merck(MRK) stock has reached 7.11M, versus its average volume of 9.52M.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
MRK News
Merck (MRK) is back on investors’ radar after recent trading left the shares around $115.91, with short term returns mixed, while the past 3 months and year hav...
This week's dividend activity included increased payouts from Colgate-Palmolive (CL) and Applied Materials (AMAT) as declarations from companies such as Microso...
Merck (NYSE:MRK) reported landmark Phase 3 results for KEYTRUDA and WELIREG-based regimens in renal, ovarian, and bladder cancers over the past two weeks. KEYT...
Analyst ratings
61%
of 31 ratingsMore MRK News
Wondering whether Merck's current share price really reflects its value, or if there is still room on the table for long term investors? Merck's stock closed a...
In late February 2026, Merck reported multiple pivotal Phase 3 successes across oncology and HIV, including KEYTRUDA- and WELIREG-based regimens in renal cell,...
In the latest close session, Merck (MRK) was up +1.14% at $117.11. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. At the same time, the...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.